Our Science Impacts Lives
Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.
482 million patients living with conditions that our pipeline aims to treat, from cancer and Alzheimer’s disease to chronic immune-mediated conditions
Therapeutic Focus Areas
Researching Areas of Unmet Medical Need
We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.
Where We Operate
Eight State-of-the-Art R&D Centers:
Lake County, Illinois, US
Redwood City, California, US
Sunnyvale, California, US (Pharmacyclics)
South San Francisco, California, US
Cambridge, Massachusetts, US
Worcester, Massachusetts, US
Technologies and Platforms
Bringing Better Solutions to Patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.
Devoted to New Discoveries
Our scientists are advancing a pipeline of specialty medicines with a focus on cancer, immune-mediated conditions, neurodegenerative diseases and more.
products with potential for new drug or indication approvals by the end of 2020
15 programs in Phase III under way
scientists working globally to make a difference
Advancing Medical Knowledge
We have investigational compounds in development within each of our therapeutic areas. A critical component of medicinal product development is clinical research, which involves conducting clinical trials to evaluate the safety and efficacy of potential new therapies.
“Discovering and developing therapies that have the potential to transform the standard of care for people battling serious and often life-threatening illnesses is our core mission.”
A Portfolio of Medicines
We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.